Clinical Trial Update: Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating isotretinoin for safety and effectiveness in HIV-infected women with cervical tumors/dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Dysplasia
• HIV Infection

Drugs mentioned

• ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Cervix, Dysplasia | Phase 3 | Status: COMPLETED